Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (PICCOLO)
Status:
Recruiting
Trial end date:
2024-05-31
Target enrollment:
Participant gender:
Summary
PICCOLO is a Phase 2, multicenter, open label study designed to evaluate the safety and
efficacy of MIRV in participants with platinum-sensitive ovarian, primary peritoneal or
fallopian tube cancers with high folate receptor-alpha (FRĪ±) expression.